retatrutide nafld Results: 28.3% Weight Loss Data Struggling With Weight? Retatrutide May

As with other incretin-based therapies, some clients may experience mild gastrointestinal symptoms (nausea, digestive discomfort) typically during the dose-adjustment phase

-Notice a significant improvement in skin texture and tone

This is an active research area with promising early signals and no definitive answers

Any significant or persistent change in stool color, particularly when paired with other symptoms, warrants a discussion with your gastroenterologist to rule out underlying conditions and ensure timely treatment

In addition, early changes in CD4 T cells may serve as a predictive marker for the risk of organ dysfunction